SCHEMBL6825969

SCHEMBL6825969

Cc1ccc(C(=O)Nc2cc[c]cc2)c(N2CCC(C)CC2)n1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SCN10A Q9Y5Y9 4/20 0.52
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 5/20 0.45
MAPT P10636 3/20 0.45
GAA P10253 2/20 0.45
KDM4E B2RXH2 2/20 0.45
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
RXFP1 Q9HBX9 1/20 0.42
KIF18A Q8NI77 4/20 0.42
GPR35 Q9HC97 1/20 0.41
TP53 P04637 1/20 0.41
TRPV1 Q8NER1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6829403 0.89 SCN10A (0.63) SCN10AALDH1A1SMN1; SMN2MAPTGAA
SCHEMBL6830991 0.86 SCN10A (0.48) SCN10AALDH1A1SMN1; SMN2MAPTGAA
SCHEMBL6828987 0.86 SCN10A (0.52) SCN10AALDH1A1KDM4EKIF18A
SCHEMBL6826031 0.82 SCN10A (0.47) SCN10AALDH1A1SMN1; SMN2MAPTGAA
SCHEMBL6643128 0.82 ALDH1A1 (0.53) SCN10AALDH1A1SMN1; SMN2MAPTGAA
SCHEMBL6829454 0.82 KMT2A (0.64) SCN10AALDH1A1SMN1; SMN2MAPTGAA
SCHEMBL6645120 0.82 ALDH1A1 (0.53) SCN10AALDH1A1SMN1; SMN2MAPTGAA
SCHEMBL6828922 0.81 SCN10A (0.48) SCN10AALDH1A1MAPTGAAKDM4E
SCHEMBL6646172 0.78 KMT2A (0.63) ALDH1A1SMN1; SMN2MAPTGAAKDM4E
SCHEMBL6645230 0.78 SMN1; SMN2 (0.44) SCN10AALDH1A1SMN1; SMN2MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004039795-A2 AMIDE COMPOUNDS FOR THE TREATMENT OF HYPERLIPIDEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-13 WO disclosed